Drug Interaction Report
2 potential interactions and/or warnings found for the following 2 drugs:
- tiludronate
- Zemdri (plazomicin)
Interactions between your drugs
tiludronate plazomicin
Applies to: tiludronate, Zemdri (plazomicin)
Using tiludronate together with plazomicin can cause damage to the kidneys and hypocalcemia (low blood calcium). Symptoms of kidney damage include swelling, weight gain, feeling short of breath, drowsiness, confusion, mood changes, increased thirst, loss of appetite, nausea and vomiting, pain in your lower back, and urinating more or less than usual or not at all. Symptoms of hypocalcemia include muscle spasms, convulsions, mental changes (irritability, depression, psychosis), increased pressure on the brain, and an irregular heartbeat. If you take both medications together, tell your doctor if you have any of these symptoms. You may need a dose adjustment or special tests to safely use these medications together. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food interactions
tiludronate food
Applies to: tiludronate
Food significantly decreases the levels of tiludronate. Tiludronate should be administered on an empty stomach with 6 to 8 ounces of plain water at least 2 hours before or 2 hours after food. This will make it easier for your body to absorb the medication.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Fosamax
Fosamax (alendronate) is used to treat or prevent postmenopausal osteoporosis and steroid-induced ...
Reclast
Reclast (zoledronic acid) is used to treat osteoporosis in women after menopause and also to treat ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Zometa
Zometa is used to treat high blood levels of calcium caused by cancer and multiple myeloma. Learn ...
Atelvia
Atelvia (risedronate) is used to treat osteoporosis in women after menopause. Includes Atelvia side ...
Actonel
Actonel (risedronate) is used to treat or prevent osteoporosis and to treat Paget's disease of ...
Miacalcin
Miacalcin nasal spray is used to treat Paget's disease, postmenopausal osteoporosis, or high levels ...
Aclasta
Aclasta (zoledronic acid) inhibits the release of calcium from bones and is used to treat Paget's ...
Aredia
Aredia is used for breast cancer, bone metastases, hypercalcemia, hypercalcemia of malignancy ...
Miacalcin Nasal
Miacalcin Nasal is used for hypercalcemia, osteogenesis imperfecta, osteoporosis, paget's disease
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.